Most Recent analysts Ratings: Murphy Oil Corporation(NYSE:MUR): Abbott Laboratories(NYSE:ABT)

0
2

Murphy Oil Corporation (MUR) will report its next earnings on Jan 30 BMO. The company reported the earnings of $0.16/Share in the last quarter where the estimated EPS by analysts was $0.17/share. The difference between the expected and actual EPS was $-0.01/share, which represents an Earnings surprise of -5.9%.

Many analysts are providing their Estimated Earnings analysis for Murphy Oil Corporation and for the current quarter 12 analysts have projected that the stock could give an Average Earnings estimate of $0.1/share. These analysts have also projected a Low Estimate of $-0.14/share and a High Estimate of $0.24/share.

In case of Revenue Estimates, 10 analysts have provided their consensus Average Revenue Estimates for Murphy Oil Corporation as 719.73 Million. According to these analysts, the Low Revenue Estimate for Murphy Oil Corporation is 666 Million and the High Revenue Estimate is 763.5 Million. The company had Year Ago Sales of 618.85 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for MUR to be 40%. They are projecting Next Quarter growth of -38.1%. For the next 5 years, Murphy Oil Corporation is expecting Growth of -60.13% per annum, whereas in the past 5 years the growth was -10.34% per annum.

Some buy side analysts are also providing their Analysis on Murphy Oil Corporation, where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 3 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.82 and Average Volume (3 months) is 2.18 million. The company’s P/E (price to earnings) ratio is 42.87 and Forward P/E ratio of 25.3.

The company shows its Return on Assets (ROA) value of 2.4%. The Return on Equity (ROE) value stands at 5.8%. While it’s Return on Investment (ROI) value is 4.3%.

While looking at the Stock’s Performance, Murphy Oil Corporation currently shows a Weekly Performance of -4.58%, where Monthly Performance is -13.05%, Quarterly performance is -11.67%, 6 Months performance is 9.81% and yearly performance percentage is -28.84%. Year to Date performance value (YTD perf) value is -21.46%. The Stock currently has a Weekly Volatility of 2.82% and Monthly Volatility of 3.27%.

Abbott Laboratories (ABT) will report its next earnings on Jan 22 BMO. The company reported the earnings of $0.95/Share in the last quarter where the estimated EPS by analysts was $0.95/share. The difference between the expected and actual EPS was $0/share, which represents an Earnings surprise of 0%.

Many analysts are providing their Estimated Earnings analysis for Abbott Laboratories and for the current quarter 16 analysts have projected that the stock could give an Average Earnings estimate of $0.71/share. These analysts have also projected a Low Estimate of $0.7/share and a High Estimate of $0.72/share.

In case of Revenue Estimates, 14 analysts have provided their consensus Average Revenue Estimates for Abbott Laboratories as 8 Billion. According to these analysts, the Low Revenue Estimate for Abbott Laboratories is 7.96 Billion and the High Revenue Estimate is 8.06 Billion. The company had Year Ago Sales of 7.47 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for ABT to be 11.1%. They are projecting Next Quarter growth of 9.76%. For the next 5 years, Abbott Laboratories is expecting Growth of 10.89% per annum, whereas in the past 5 years the growth was 11.11% per annum.

Some buy side analysts are also providing their Analysis on Abbott Laboratories, where 4 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 1 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 1.19 and Average Volume (3 months) is 4.66 million. The company’s P/E (price to earnings) ratio is 41.85 and Forward P/E ratio of 21.1.

The company shows its Return on Assets (ROA) value of 4.3%. The Return on Equity (ROE) value stands at 9.3%. While it’s Return on Investment (ROI) value is 6.1%.

While looking at the Stock’s Performance, Abbott Laboratories currently shows a Weekly Performance of -5.61%, where Monthly Performance is -6.72%, Quarterly performance is 0.88%, 6 Months performance is 0.31% and yearly performance percentage is 11.17%. Year to Date performance value (YTD perf) value is -2.57%. The Stock currently has a Weekly Volatility of 1.52% and Monthly Volatility of 1.44%.

SHARE